Latest 8-K filings

International Paper announced the appointment of Katherine Collins and Lori J. Ryerkerk to its Board of Directors, effective October 1, 2026, while Dr. Kathryn Sullivan and Ahmet C. Dorduncu will retire at year-end.

Lindsay Corporation announced the resignation of its Senior Vice President and Chief Financial Officer, Sam Hinrichsen, effective August 31, 2026, citing personal reasons.

iBio, Inc. announced its 2026 Annual Meeting of Stockholders will be held on October 14, 2026, and has updated deadlines for shareholder proposals and director nominations.

Grayscale SUI Staking ETF announces an amendment to its trust agreement to enable regular distributions of staking rewards to shareholders, effective August 7, 2026.

Tvardi Therapeutics announced an increase to its at-the-market offering program, allowing for the issuance of up to an additional $9.69 million in common stock.

Dare Bioscience has received a notice from Nasdaq indicating its common stock is subject to delisting due to non-compliance with minimum stockholders' equity requirements.

Trinseo PLC has announced its annual general meeting of shareholders will be held on September 23, 2026, with a record date of July 30, 2026.

Grayscale Solana Staking ETF announces a Third Amended and Restated Declaration of Trust and Trust Agreement, introducing regular distributions of staking rewards and other operational updates.

Deep Fission, Inc. announced an increase in authorized shares for its 2025 Equity Incentive Plan and ratified its independent auditor at its annual meeting.

Polomar Health Services, Inc. has dismissed GreenGrowth CPAs and appointed Haskell & White LLP as its new independent registered public accounting firm.

TransCode Therapeutics, Inc. has amended its Certificate of Designation for Series C Non-Voting Convertible Preferred Stock, increasing the beneficial ownership limitation.

enGene Therapeutics Inc. has released an updated corporate presentation on July 17, 2026, detailing the progress of its lead investigational drug, detalimogene voraplasmid, for Non-Muscle Invasive Bladder Cancer (NMIBC).

EyePoint, Inc. has entered into a settlement agreement with the U.S. Department of Justice to resolve allegations related to past sales and marketing practices for DEXYCU, agreeing to pay $4.7 million and enter a five-year Corporate Integrity Agreement.

Grayscale Ethereum Staking ETF announces a Fourth Amended and Restated Declaration of Trust and Trust Agreement, introducing regular distributions of staking rewards and other operational adjustments.

Clover Health disclosed a cybersecurity incident on July 4, 2026, involving unauthorized access to employee accounts, with an ongoing investigation into data impact.

Csquare, Inc. announced the successful completion of its initial public offering (IPO), raising $1,010.0 million in net proceeds.

Grayscale Ethereum Staking Mini ETF announces a Third Amended and Restated Declaration of Trust and Trust Agreement, effective around August 7, 2026, to facilitate regular distributions of staking rewards.

SB Financial Group announced its board has declared a quarterly cash dividend of $0.16 per common share, a 7% increase from the prior year.

ARS Pharmaceuticals announced the resignation of a board director and the departure of its Chief Medical Officer, effective July 15, 2026, with associated severance payments.

Grayscale Avalanche Staking ETF announces an amendment to its trust agreement to facilitate regular distributions of staking rewards to shareholders.

Trans American Aquaculture announced that its previously issued 2024 financial statements must be restated due to material errors in financial reporting.

Nancy Lipson resigns from Frontier Group Holdings' Board of Directors to pursue a new business opportunity.

Gogo Inc. announces an internal reorganization and executive role change for Hayden Olson, effective July 15, 2026.

Organon & Co. provides an update on its merger with Sun Pharma, including supplemental disclosures to its proxy statement and details on ongoing litigation.

GoodVision AI announces the establishment of its first next-generation AI Factory in Fukushima, Japan, through a strategic partnership with AI Storm, aiming for 100 MW capacity within three years.

Fuse Science, Inc. has been placed under court-ordered receivership, leading to the resignation of all prior officers and directors and the appointment of new interim management.

Archimedes Tech SPAC Partners III Co. announced the immediate appointment of Stephen N. Cannon as a Class II director, effective July 13, 2026.

NextTrip, Inc. announced the appointment of Casey D'Ambra as President of Media, effective July 13, 2026, with a base salary of $205,000 and potential bonus.

CO2 Energy Transition Corp. has signed a non-binding letter of intent with a Texas-based energy company to recover lithium and strontium from brines for defense applications.

Ares Real Estate Income Trust Inc. provides an update on its Net Asset Value (NAV) as of June 30, 2026, and details its real estate portfolio composition and recent acquisitions.